Machine Learning Guided Discovery of Non-Hemolytic Membrane Disruptive Anticancer Peptides

August 17, 2022

Title

Machine Learning Guided Discovery of Non-Hemolytic Membrane Disruptive Anticancer Peptides

Author

Elena Zakharova, Markus Orsi, Alice Capecchi, Prof. Dr. Jean-Louis Reymond

Year

2022

Journal

Chem Med Chem

Abstract

Most antimicrobial peptides (AMPs) and anticancer peptides (ACPs) fold into membrane disruptive cationic amphiphilic α-helices, many of which are however also unpredictably hemolytic and toxic. Here we exploited the ability of recurrent neural networks (RNN) to distinguish active from inactive and non-hemolytic from hemolytic AMPs and ACPs to discover new non-hemolytic ACPs. Our discovery pipeline involved: 1) sequence generation using either a generative RNN or a genetic algorithm, 2) RNN classification for activity and hemolysis, 3) selection for sequence novelty, helicity and amphiphilicity, and 4) synthesis and testing. Experimental evaluation of thirty-three peptides resulted in eleven active ACPs, four of which were non-hemolytic, with properties resembling those of the natural ACP lasioglossin III. These experiments show the first example of direct machine learning guided discovery of non-hemolytic ACPs.

Instrument

J-715

Keywords

machine learning, Antimicrobial peptide, AMPs, anticanser peptide, ACPs